Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Please use this identifier to cite or link to this item:
http://bura.brunel.ac.uk/handle/2438/12702| Title: | Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICE |
| Authors: | Greenhalgh, J Longworth, L Crossan, C Singh, J Bagust, A Beale, S Richardson, M Banks, L Kotas, E Hall, M |
| Keywords: | Guidance;Edoxaban;Stroke;Prevention;Systemic embolism |
| Issue Date: | 2015 |
| Publisher: | National Institute for Health and Care Excellence (NICE) |
| Citation: | Greenhalgh, J., Longworth, L., Crossan, C., Singh, J., Bagust, A., Beale, S., Richardson, M., Banks, L., Kotas, E. and Hall, M. (September 2015) 'Edoxaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation: A Single Technology Appraisal. Evidence Review Group Report to NICE', NICE technology appraisal guidance (TA355), pp. 1 - 40. ISBN: 978-1-4731-1440-1. |
| Abstract: | 1.1 Edoxaban is recommended, within its marketing authorisation, as an option for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation with one or more risk factors, including: congestive heart failure hypertension diabetes prior stroke or transient ischaemic attack age 75 years or older. |
| URI: | https://bura.brunel.ac.uk/handle/2438/12702 |
| ISBN: | 978-1-4731-1440-1 |
| Appears in Collections: | Health Economics Research Group (HERG) |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Fulltext.pdf | 232.75 kB | Adobe PDF | View/Open |
Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.